Pfizer Global Supply (PGS) Inaugurates New Manufacturing Technology in Germany
Local leaders, Pfizer colleagues and guests inaugurated the new Portable, Continuous, Miniature and Modular (PCMM) technology in Freiburg, Germany.
"This milestone - almost 20 years in the making - represents a true paradigm shift in pharmaceutical manufacturing," said Kevin Nepveux, who leads Launch Excellence for PGS.
Compared to batch manufacturing, PCMM allows continuous manufacturing - moving from powder to tablets in minutes, eliminating variation and bringing new products to market more quickly, while supporting Pfizer's commitment to sustainability.
Since construction began in April 2017, the team has rapidly ramped up the PCMM line in Freiburg for commercial manufacturing of a medicine. Pharmaceutical Sciences and PGS are committed to PCMM as the primary platform for solid oral dose products moving forward.
Ian Read: Contributions to Improving Human Health
Albert Bourla: Breakthroughs that Change Patients' Lives
Ushering in a New Era of Pfizer R&D Productivity
Advancing Our Leading JAK Science
Overcoming Therapy-Resistant Disease
Tackling Respiratory Syncytial Virus (RSV) Through Breakthrough Science and Technology
Catalyzing Innovations in Global Health
Contributing to the UN Sustainable Development Goals
Supporting Digital Health Start-Ups
Improving the Health of Women and Their Families